Abstract Details
| Joel Berniac (Paratek Pharmaceuticals, Inc.) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Daniel Coovert, BS | No disclosure on file |
| No disclosure on file | |
| Paul Higgins (Paratek Pharmaceuticals) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file |